IL-17 producing innate lymphoid cells 3 (ILC3) but not Th17 cells might be the potential danger factor for preeclampsia and other pregnancy associated diseases

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 9, 2015, Pages 11100-11107

  Barnie, Prince A ^a,b   Lin, Xin ^c   Liu, Yueqin ^c   Xu, Huaxi ^a   Su, Zhaoliang ^a,c  

^a JIANGSU UNIVERSITY   (China)

^b UNIVERSITY OF CAPE COAST   (Ghana)

^c The Fourth People's Hospital of Zhenjiang   (China)

Author keywords

Gestational diabetes; Innate lymphoid cells; Preeclampsia; Th17 cells

Indexed keywords

BIOLOGICAL MARKER; GAMMA INTERFERON; HIGH MOBILITY GROUP B1 PROTEIN; HMGB1 PROTEIN, HUMAN; IFNG PROTEIN, HUMAN; IL1B PROTEIN, HUMAN; INTERLEUKIN 17; INTERLEUKIN 1BETA;

ADULT; BLOOD; CASE CONTROL STUDY; DIABETES, GESTATIONAL; FEMALE; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE; METABOLISM; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY IN DIABETICS; RISK FACTOR; TH17 CELL; UPREGULATION; YOUNG ADULT;

ADULT; BIOMARKERS; CASE-CONTROL STUDIES; DIABETES, GESTATIONAL; FEMALE; HMGB1 PROTEIN; HUMANS; IMMUNITY, INNATE; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-1BETA; LYMPHOCYTES; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY IN DIABETICS; RISK FACTORS; TH17 CELLS; UP-REGULATION; YOUNG ADULT;

EID: 84960182020     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Parham P. NK Cells and Trophoblasts Partners in Pregnancy. J Exp Med 2004; 200: 951-955.
2. Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y. The role of the immune system in preeclampsia. Mol Aspects Med 2007; 28: 192-209.
3. Baumwell S, Karumanchi SA. Pre-eclampsia: clinical manifestations and molecular mechanisms. Nephron Clin Pract 2006; 106: c72-81.
4. Kjos SL, Buchanan TA. Gestational diabetes mellitus. N Engl J Med 1999; 341: 1749-1756.
5. Guerin LR, Prins JR, Robertson SA. Regulatory T-cells and immune tolerance in pregnancy: a new target for infertility treatment? Hum Reprod Update 2009; 15: 517-535.
6. Munoz-Suano A, Hamilton AB, Betz AG. Gimme shelter: the immune system during pregnancy. Immunol Rev 2011; 241: 20-38.
7. Gomes CP, Torloni MR, Gueuvoghlanian-Silva BY, Alexandre SM, Mattar R, Daher S. Cytokine levels in gestational diabetes mellitus: a systematic review of the literature. Am J Reprod Immunol 2013; 69: 545-557.
8. Clark DA, Coulam CB, Daya S, Chaouat G. Unexplained sporadic and recurrent miscarrage in the new millennium: a critical analysis of immune mechanisms and treatments. Hum Reprod Update 2001; 7: 501-511.
9. Nakashima A, Ito M, Yoneda S, Shiozaki A, Hidaka T, Saito S. Short communication: Circulating and Decidual Th17 Cell Levels in Healthy Pregnancy. Am J Reprod Immunol 2010; 63: 104-109.
10. Sutton CE, Mielke LA, Mills KH: IL-17-producing γδT cells and innate lymphoid cells. Eur J Immunol 2012; 42: 2221-2231.
11. Sedda S, Marafini I, Figliuzzi MM, Pallone F, Monteleone G. An Overview of the Role of Innate Lymphoid Cells in Gut Infections and Inflammation. Mediators Inflamm 2014; 2014: 235460.
12. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie AN, Mebius RE. Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol 2013; 13: 145-149.
13. Spits H, Cupedo T. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Ann Rev Immunol 2012; 30: 647-675.
14. Walker JA, Barlow JL, McKenzie AN. Innate lymphoid cells-how did we miss them? Nat Rev Immunol 2013; 13: 75-87.
15. Mjösberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B, Fokkens WJ, Cupedo T, Spits H. Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol 2011; 12: 1055-1062.
16. Bernink JH, Peters CP, Munneke M, te Velde AA, Meijer SL, Weijer K, Hreggvidsdottir HS, Heinsbroek SE, Legrand N, Buskens CJ. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat Immunol 2013; 14: 221-229.
17. Roediger B, Kyle R, Yip KH, Sumaria N, Guy TV, Kim BS, Mitchell AJ, Tay SS, Jain R, Forbes-Blom E. Cutaneous immunosurveillance and regulation of inflammation by group 2 innate lymphoid cells. Nat Immunol 2013; 14: 564-573.
18. Sherkat R, Yazdani R, Hakemi MG, Homayouni V, Farahani R, Hosseini M, Rezaei A. Innate lymphoid cells and cytokines of the novel subtypes of helper T cells in asthma. Asia Pacific Allergy 2014; 4: 212.
19. Wallace K, Dhillon P, Richards S, Weimer A, Martin JN Jr, LaMarca B. Interleukin 17 increases blood pressure during pregnancy: a link between autoimmunity and preeclampsia? FASEB J 2011; 25: 1030.1010.
20. Dhillon P. Activation of IL-17 during pregnancy; a link between autoimmunity and preeclampsia: The university of mississippi medical center; 2012.
21. Brown M, Hague W, Higgins J, Lowe S, McCowan L, Oats J, Peek M, Rowan J, Walters B. The detection, investigation and management of hypertension in pregnancy: full consensus statement. Aust N Z J Obstet Gynaecol 2000; 40: 139-155.
22. Sonnenberg GF. Regulation of intestinal health and disease by innate lymphoid cells. Int Immunol 2014; 26: 501-7.
23. Hijnen D, Knol EF, Gent YY, Giovannone B, Beijn SJ, Kupper TS, Bruijnzeel-Koomen CA, Clark RA. CD8(+) T Cells in the Lesional Skin of Atopic Dermatitis and Psoriasis Patients Are an Important Source of IFN-γ, IL-13, IL-17, and IL-22. J Invest Dermatol 2013; 133: 973-979.
24. Pantelyushin S, Haak S, Ingold B, Kulig P, Heppner FL, Navarini AA, Becher B: Rorγt+ innate lymphocytes and γδ T cells initiate psoriasiform plaque formation in mice. J Clin Invest 2012; 122: 2252-2256.
25. Geremia A, Arancibia-Cárcamo CV, Fleming MP, Rust N, Singh B, Mortensen NJ, Travis SP, Powrie F. IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease. J Exp Med 2011; 208: 1127-1133.
26. Van Kooten C, Boonstra JG, Paape ME, Fossiez F, Banchereau J, Lebecque S, Bruijn J, De Fijter J, Van Es L, Daha M. Interleukin-17 activates human renal epithelial cells in vitro and is expressed during renal allograft rejection. J Am Soc Nephrol 1998; 9: 1526-1534.
27. Tang JL, Subbotin VM, Antonysamy MA, Troutt AB, Rao AS, Thomson AW. Interleukin-17 antagonism inhibits acute but not chronic vascular rejection1. Transplantation 2001; 72: 348-350.
28. Saito S, Tsukaguchi N, Hasegawa T, Michimata T, Tsuda H, Narita N. Distribution of Th1, Th2, and Th0 and the Th1/Th2 cell ratios in human peripheral and endometrial T cells. Am J Reprod Immunol 1999; 42: 240-245.
29. Saito S, Umekage H, Sakamoto Y, Sakai M, Tanebe K, Sasaki Y, Morikawa H. Increased T-Helper-1-Type Immunity and Decreased T-Helper-2-Type Immunity in Patients with Preeclampsia. Am J Reprod Immunol 1999; 41: 297-306.
30. Santner-Nanan B, Peek MJ, Khanam R, Richarts L, Zhu E, de St Groth BF, Nanan R. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsia. J Immunol 2009; 183: 7023-7030.
31. Toldi G, Rigó J, Stenczer B, Vásárhelyi B, Molvarec A. Increased Prevalence of IL-17-Producing Peripheral Blood Lymphocytes in Pre-eclampsia. Am J Reprod Immunol 2011; 66: 223-229.
32. Hasegawa E, Sonoda K-H, Shichita T, Morita R, Sekiya T, Kimura A, Oshima Y, Takeda A, Yoshimura T, Yoshida S. IL-23-Independent Induction of IL-17 from γδT Cells and Innate Lymphoid Cells Promotes Experimental Intraocular Neovascularization. J Immunol 2013; 190: 1778-1787.
33. Hoorweg K, Peters CP, Cornelissen F, Aparicio-Domingo P, Papazian N, Kazemier G, Mjösberg JM, Spits H, Cupedo T. Functional differences between human NKp44-and NKp44+ RORC+ innate lymphoid cells. Front Immunol 2012; 3: 72.
34. Glatzer T, Killig M, Meisig J, Ommert I, Luetke-Eversloh M, Babic M, Paclik D, Blüthgen N, Seidl R, Seifarth C. RORγt+ innate lymphoid cells acquire a proinflammatory program upon engagement of the activating receptor NKp44. Immunity 2013; 38: 1223-1235.
35. Awasthi A, Kuchroo VK. Th17 cells: from precursors to players in inflammation and infection. Int Immunol 2009; 21: 489-9836.
36. Ito M, Nakashima A, Hidaka T, Okabe M, Bac ND, Ina S, Yoneda S, Shiozaki A, Sumi S, Tsuneyama K. A role for IL-17 in induction of an inflammation at the fetomaternal interface in preterm labour. J Reprod Immunol 2010; 84: 75-85.
37. Nakashima A, Ito M, Shima T, Bac ND, Hidaka T, Saito S. Accumulation of IL-17-Positive Cells in Decidua of Inevitable Abortion Cases. Am J Reprod Immunol 2010; 64: 4-11.
38. Pongcharoen S, Niumsup P, Sanguansermsri D, Supalap K, Butkhamchot P. The Effect of Interleukin-17 on the Proliferation and Invasion of JEG-3 Human Choriocarcinoma Cells. Am J Reprod Immunol 2006; 55: 291-300.